Charbit-Henrion F, Lacaille F, McKiernan P, Girard M, de Lonlay P, Valayannopoulos V, Ottolenghi C, Chakrapani A, Preece M, Sharif K, Chardot C, Hubert P, Dupic L
Laboratory of Intestinal Immunity, Unité INSERM UMR1163, Institut IMAGINE, Paris, France.
Am J Transplant. 2015 Mar;15(3):786-91. doi: 10.1111/ajt.13027. Epub 2015 Feb 12.
Propionic acidemia (PA) is a severe metabolic disorder with cardiac and neurologic complications and a poor quality of life. Liver transplantation (LT) was thus proposed in PA to increase enzyme activity. We studied retrospectively LT in PA in two European centers. Twelve patients underwent 17 LTs between 1991 and 2013. They developed severe, unusual and unexpected complications, with high mortality (58%). When present, the cardiomyopathy resolved and no acute metabolic decompensation occurred allowing dietary relaxation. Renal failure was present in half of the patients before LT and worsened in all of them. We suggest that cardiac and renal functions should be assessed before LT and monitored closely afterward. A renal sparing immunosuppression should be used. We speculate that some complications may be related to accumulated toxicity of the disease and that earlier LT could prevent some of these consequences. As kidney transplantation has been performed successfully in methylmalonic acidemia, a metabolic disease in the same biochemical pathway, the choice of the organ to transplant could be further discussed.
丙酸血症(PA)是一种严重的代谢紊乱疾病,伴有心脏和神经并发症,生活质量较差。因此,有人提出进行肝移植(LT)以提高PA患者的酶活性。我们在两个欧洲中心对PA患者的肝移植情况进行了回顾性研究。1991年至2013年间,12例患者接受了17次肝移植。他们出现了严重、异常且意想不到的并发症,死亡率很高(58%)。出现的心肌病得到缓解,未发生急性代谢失代偿,从而可以放宽饮食限制。一半的患者在肝移植前就已出现肾衰竭,且所有患者的肾衰竭情况均有所恶化。我们建议在肝移植前评估心脏和肾功能,并在术后密切监测。应采用肾脏保护型免疫抑制方案。我们推测,一些并发症可能与该疾病的累积毒性有关,早期进行肝移植或许可以预防其中一些后果。由于在甲基丙二酸血症(同一生化途径中的一种代谢疾病)中已成功进行了肾移植,因此对于移植器官的选择可作进一步探讨。